Loss of HLA haplotype and B locus down-regulation in melanoma cell lines

Francesco M. Marincola, Peter Shamamian, Richard B. Alexander, James R. Gnarra, Regina L. Turetskaya, Sergei A. Nedospasov, Toni B. Simonis, Jeffery K. Taubenberger, John Yannelli, Arnold Mixon, Nicholas P. Restifo, Meenhard Herlyn, Steven A. Rosenberg

Research output: Contribution to journalArticle

163 Citations (Scopus)

Abstract

The expression of HLA class I molecules on tumor cells is vital for CD8+ T cell recognition of tumor Ags. Loss of HLA class I Ag expression as a result of defective β2-microglobulin genes has been described in melanoma cells. To further evaluate mechanisms of tumor escape, HLA class I Ag expression was compared in 24 metastatic melanoma cell lines and 20 melanocyte strains by FACS analysis with use of allele-specific mAbs. Total loss of HLA class I Ag expression was not noted; instead, two relatively common phenomena were identified: 1) A variable degree of expression of HLA- B Ags by melanoma cell lines and melanocytes; however, HLA-A Ags were consistently expressed in all cell types. Furthermore, HLA-B locus Ag expression was detected in vivo in only one of six frozen section specimens obtained from six patients having metastatic melanoma. 2) Loss of allelic expression was noted in two of 14 HLA-A2 (14%) and one of three HLA-A29 (33%) melanoma cell lines and included a full haplotype, which suggests loss of a genomic fragment. Allele-specific PCR amplification demonstrated deletion of genes in linkage disequilibrium within the MHC class II, III, and I regions. Aberrations of HLA class I expression in tumor lines should be considered when assessing MHC-restricted phenomena in in vitro models.

Original languageEnglish (US)
Pages (from-to)1225-1237
Number of pages13
JournalJournal of Immunology
Volume153
Issue number3
StatePublished - Aug 1 1994
Externally publishedYes

Fingerprint

HLA-B Antigens
Haplotypes
Melanoma
Down-Regulation
Cell Line
Melanocytes
Alleles
Tumor Escape
HLA-A2 Antigen
Neoplasms
HLA-A Antigens
Loss of Heterozygosity
Linkage Disequilibrium
Gene Deletion
Frozen Sections
T-Lymphocytes
Polymerase Chain Reaction
Genes

ASJC Scopus subject areas

  • Immunology

Cite this

Marincola, F. M., Shamamian, P., Alexander, R. B., Gnarra, J. R., Turetskaya, R. L., Nedospasov, S. A., ... Rosenberg, S. A. (1994). Loss of HLA haplotype and B locus down-regulation in melanoma cell lines. Journal of Immunology, 153(3), 1225-1237.

Loss of HLA haplotype and B locus down-regulation in melanoma cell lines. / Marincola, Francesco M.; Shamamian, Peter; Alexander, Richard B.; Gnarra, James R.; Turetskaya, Regina L.; Nedospasov, Sergei A.; Simonis, Toni B.; Taubenberger, Jeffery K.; Yannelli, John; Mixon, Arnold; Restifo, Nicholas P.; Herlyn, Meenhard; Rosenberg, Steven A.

In: Journal of Immunology, Vol. 153, No. 3, 01.08.1994, p. 1225-1237.

Research output: Contribution to journalArticle

Marincola, FM, Shamamian, P, Alexander, RB, Gnarra, JR, Turetskaya, RL, Nedospasov, SA, Simonis, TB, Taubenberger, JK, Yannelli, J, Mixon, A, Restifo, NP, Herlyn, M & Rosenberg, SA 1994, 'Loss of HLA haplotype and B locus down-regulation in melanoma cell lines', Journal of Immunology, vol. 153, no. 3, pp. 1225-1237.
Marincola FM, Shamamian P, Alexander RB, Gnarra JR, Turetskaya RL, Nedospasov SA et al. Loss of HLA haplotype and B locus down-regulation in melanoma cell lines. Journal of Immunology. 1994 Aug 1;153(3):1225-1237.
Marincola, Francesco M. ; Shamamian, Peter ; Alexander, Richard B. ; Gnarra, James R. ; Turetskaya, Regina L. ; Nedospasov, Sergei A. ; Simonis, Toni B. ; Taubenberger, Jeffery K. ; Yannelli, John ; Mixon, Arnold ; Restifo, Nicholas P. ; Herlyn, Meenhard ; Rosenberg, Steven A. / Loss of HLA haplotype and B locus down-regulation in melanoma cell lines. In: Journal of Immunology. 1994 ; Vol. 153, No. 3. pp. 1225-1237.
@article{39bbc0bf6bf34e5884f5724cd41e2658,
title = "Loss of HLA haplotype and B locus down-regulation in melanoma cell lines",
abstract = "The expression of HLA class I molecules on tumor cells is vital for CD8+ T cell recognition of tumor Ags. Loss of HLA class I Ag expression as a result of defective β2-microglobulin genes has been described in melanoma cells. To further evaluate mechanisms of tumor escape, HLA class I Ag expression was compared in 24 metastatic melanoma cell lines and 20 melanocyte strains by FACS analysis with use of allele-specific mAbs. Total loss of HLA class I Ag expression was not noted; instead, two relatively common phenomena were identified: 1) A variable degree of expression of HLA- B Ags by melanoma cell lines and melanocytes; however, HLA-A Ags were consistently expressed in all cell types. Furthermore, HLA-B locus Ag expression was detected in vivo in only one of six frozen section specimens obtained from six patients having metastatic melanoma. 2) Loss of allelic expression was noted in two of 14 HLA-A2 (14{\%}) and one of three HLA-A29 (33{\%}) melanoma cell lines and included a full haplotype, which suggests loss of a genomic fragment. Allele-specific PCR amplification demonstrated deletion of genes in linkage disequilibrium within the MHC class II, III, and I regions. Aberrations of HLA class I expression in tumor lines should be considered when assessing MHC-restricted phenomena in in vitro models.",
author = "Marincola, {Francesco M.} and Peter Shamamian and Alexander, {Richard B.} and Gnarra, {James R.} and Turetskaya, {Regina L.} and Nedospasov, {Sergei A.} and Simonis, {Toni B.} and Taubenberger, {Jeffery K.} and John Yannelli and Arnold Mixon and Restifo, {Nicholas P.} and Meenhard Herlyn and Rosenberg, {Steven A.}",
year = "1994",
month = "8",
day = "1",
language = "English (US)",
volume = "153",
pages = "1225--1237",
journal = "Journal of Immunology",
issn = "0022-1767",
publisher = "American Association of Immunologists",
number = "3",

}

TY - JOUR

T1 - Loss of HLA haplotype and B locus down-regulation in melanoma cell lines

AU - Marincola, Francesco M.

AU - Shamamian, Peter

AU - Alexander, Richard B.

AU - Gnarra, James R.

AU - Turetskaya, Regina L.

AU - Nedospasov, Sergei A.

AU - Simonis, Toni B.

AU - Taubenberger, Jeffery K.

AU - Yannelli, John

AU - Mixon, Arnold

AU - Restifo, Nicholas P.

AU - Herlyn, Meenhard

AU - Rosenberg, Steven A.

PY - 1994/8/1

Y1 - 1994/8/1

N2 - The expression of HLA class I molecules on tumor cells is vital for CD8+ T cell recognition of tumor Ags. Loss of HLA class I Ag expression as a result of defective β2-microglobulin genes has been described in melanoma cells. To further evaluate mechanisms of tumor escape, HLA class I Ag expression was compared in 24 metastatic melanoma cell lines and 20 melanocyte strains by FACS analysis with use of allele-specific mAbs. Total loss of HLA class I Ag expression was not noted; instead, two relatively common phenomena were identified: 1) A variable degree of expression of HLA- B Ags by melanoma cell lines and melanocytes; however, HLA-A Ags were consistently expressed in all cell types. Furthermore, HLA-B locus Ag expression was detected in vivo in only one of six frozen section specimens obtained from six patients having metastatic melanoma. 2) Loss of allelic expression was noted in two of 14 HLA-A2 (14%) and one of three HLA-A29 (33%) melanoma cell lines and included a full haplotype, which suggests loss of a genomic fragment. Allele-specific PCR amplification demonstrated deletion of genes in linkage disequilibrium within the MHC class II, III, and I regions. Aberrations of HLA class I expression in tumor lines should be considered when assessing MHC-restricted phenomena in in vitro models.

AB - The expression of HLA class I molecules on tumor cells is vital for CD8+ T cell recognition of tumor Ags. Loss of HLA class I Ag expression as a result of defective β2-microglobulin genes has been described in melanoma cells. To further evaluate mechanisms of tumor escape, HLA class I Ag expression was compared in 24 metastatic melanoma cell lines and 20 melanocyte strains by FACS analysis with use of allele-specific mAbs. Total loss of HLA class I Ag expression was not noted; instead, two relatively common phenomena were identified: 1) A variable degree of expression of HLA- B Ags by melanoma cell lines and melanocytes; however, HLA-A Ags were consistently expressed in all cell types. Furthermore, HLA-B locus Ag expression was detected in vivo in only one of six frozen section specimens obtained from six patients having metastatic melanoma. 2) Loss of allelic expression was noted in two of 14 HLA-A2 (14%) and one of three HLA-A29 (33%) melanoma cell lines and included a full haplotype, which suggests loss of a genomic fragment. Allele-specific PCR amplification demonstrated deletion of genes in linkage disequilibrium within the MHC class II, III, and I regions. Aberrations of HLA class I expression in tumor lines should be considered when assessing MHC-restricted phenomena in in vitro models.

UR - http://www.scopus.com/inward/record.url?scp=0028239376&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0028239376&partnerID=8YFLogxK

M3 - Article

VL - 153

SP - 1225

EP - 1237

JO - Journal of Immunology

JF - Journal of Immunology

SN - 0022-1767

IS - 3

ER -